title: Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial.
authors.forename: Anneke
authors.initials: A
authors.lastname: Grobler
authors.forename: Salim
authors.initials: S
authors.lastname: Abdool Karim
mesh_terms: D016915:AIDS Vaccines; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D017589:Immunization Programs / Q000706:statistics & numerical data*; D016032:Randomized Controlled Trials as Topic / Q000592:standards*
chemical_list: D016915:AIDS Vaccines